A method for the calculation of bioavailability in slow release formulations in the presence of within-individual variability

[1]  P. Veng‐Pedersen.  Drug absorption evaluation in the presence of changes in clearance: an algorithm and computer program for deconvolution with exact clearance correction. , 1987, Biopharmaceutics & drug disposition.

[2]  D. Cutler.  Definition of mean residence times in pharmacokinetics. , 1987, Biopharmaceutics & drug disposition.

[3]  M. Bialer,et al.  The relationship between drug input and mean residence time in the body. , 1986, Biopharmaceutics & drug disposition.

[4]  Weiner Dl.  NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. , 1986 .

[5]  D. Brockmeier,et al.  Mean residence time. , 1986, Methods and findings in experimental and clinical pharmacology.

[6]  J. Proost.  Application of a numerical deconvolution technique in the assessment of bioavailability. , 1985, Journal of pharmaceutical sciences.

[7]  E. Nüesch.  Noncompartmental approach in pharmacokinetics using moments. , 1984, Drug metabolism reviews.

[8]  W. L. Chiou,et al.  Plasma area method in relative bioavailability evaluation of drugs with changing biological half-lives. , 1981, Journal of pharmaceutical sciences.

[9]  P. Pedersen,et al.  Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response I: Theoretical analysis. , 1980, Journal of pharmaceutical sciences.

[10]  D. Cutler,et al.  Theory of the mean absorption time, an adjunct to conventional bioavailability studies , 1978, The Journal of pharmacy and pharmacology.